Dr. Black is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Level 6, 2775 Laurel St
Seattle, WA 98117Phone+1 604-875-4301- Is this information wrong?
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2005 - 2008
University of WashingtonResidency, Urology, 2001 - 2005- University of WashingtonResidency, Surgery, 1999 - 2001
Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1997
Certifications & Licensure
- American Board of Urology Urology
- Royal College of Physicians and Surgeons, CanadaUrology
Clinical Trials
- Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer Start of enrollment: 2021 Sep 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.Lee, B., Smith, A., Lotan, Y., Agarwal, P., Black, P., Dickstein, R., Kamat, A., Narayan, V., Porten, S., Psutka, S., Svatek, R., Williams, S., Woldu, S.> ;Urologic Oncology. 2024 Feb 1
- 2 citationsClassifying Pulmonary and Urinary High-grade Neuroendocrine Carcinoma by CK7 Immunohistochemistry.Jiaming Fan, Henry Li, Chen Zhou, Wei Xiong, Carlos Villamil, Diana Ionescu, Htoo Z Oo, Alberto Contreras-Sanz, Gang Wang, Black, P.> ;Applied Immunohistochemistry & Molecular Morphology. 2022 Jul 1
- 16 citationsPredictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture.Haoyang Mi, Trinity J. Bivalacqua, Max Kates, Roland Seiler, Peter C. Black, Aleksander S. Popel, Alexander S. Baras> ;Cell Reports. Medicine. 2021 Jul 27
- Join now to see all
Press Mentions
EAU 2018: Who Benefits from Neoadjuvant Chemotherapy and Who Needs Immediate Radical Treatment?March 20th, 2018
Expert Discusses Next Steps for Durvalumab in Bladder CancerAugust 23rd, 2017
Immune Cells the Missing Ingredient in New Bladder Cancer TreatmentJuly 24th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
